...
首页> 外文期刊>Biochemical Pharmacology >Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase pi inhibitor.
【24h】

Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase pi inhibitor.

机译:在长期暴露于谷胱甘肽S-转移酶pi抑制剂的HL60细胞系中,对佛波醇12-肉豆蔻酸酯13-乙酸酯诱导的细胞生长停滞具有抵抗力。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Glutathione S-transferase pi (GSTpi; EC 2.5.1.18) has been shown recently to be a regulator of mitogen-activated protein kinases (MAPK). We have developed, by chronic exposure of HL60 cells to increasing concentrations of a peptidomimetic GSTpi inhibitor TLK199, a 10-fold resistant cell line (HL60/TLK199). Among the cellular adaptations observed in this cell line was an increase in extracellular signal-regulated kinase (ERK) activity without modification of basal expression levels. Phorbol 12-myristate 13-acetate (PMA) induced monocyte/macrophage cytodifferentiation in both HL60 wild-type (WT) and HL60/TLK199 cells. In contrast, PMA induced a pronounced cell growth inhibition and G(0)/G(1) cell cycle arrest in HL60 WT cells, while this differentiating agent had only a mild effect on cell growth without G(0)/G(1) cell cycle arrest in HL60/TLK199. This effect was associated with a rapid and sustained activation of ERK (up to 6hr) in HL60 WT cells but only a transient induction of these kinases (between 30 and 60min) in HL60/TLK199. Furthermore, treatment of both cell lines with PMA in combination with the protein tyrosine phosphatase inhibitors sodium orthovanadate (OV) or 3,4-dephostatin (DPN) circumvented the resistance to cell growth arrest and potentiated differentiation in HL60/TLK199 but had no effect on HL60 WT cells. The circumvention of the resistance to PMA was associated with a sustained activation of ERK. These data suggest that chronic exposure of HL60 cells to TLK199 alters cellular ERK activation by PMA, which may contribute to the differential response of the WT and resistant cells to PMA.
机译:谷胱甘肽S-转移酶pi(GSTpi; EC 2.5.1.18)最近被证明是促分裂原活化蛋白激酶(MAPK)的调节剂。通过将HL60细胞长期暴露于浓度增加的拟肽GSTpi抑制剂TLK199,我们已经开发出了10倍耐药细胞系(HL60 / TLK199)。在此细胞系中观察到的细胞适应性变化是细胞外信号调节激酶(ERK)活性增加,而基础表达水平没有改变。 Pholbol 12-肉豆蔻酸酯13-乙酸酯(PMA)在HL60野生型(WT)和HL60 / TLK199细胞中诱导单核细胞/巨噬细胞的细胞分化。相反,PMA在HL60 WT细胞中诱导了明显的细胞生长抑制和G(0)/ G(1)细胞周期停滞,而这种分化剂对没有G(0)/ G(1)的细胞生长仅具有轻微的影响。 HL60 / TLK199中的细胞周期停滞。这种作用与HL60 WT细胞中ERK的快速持续活化(长达6小时)有关,而在HL60 / TLK199中仅短暂诱导了这些激酶(30-60分钟之间)。此外,将PMA与蛋白酪氨酸磷酸酶抑制剂原钒酸钠(OV)或3,4-去磷酸他汀(DPN)联合使用可对两种细胞系进行处理,从而在HL60 / TLK199中规避了对细胞生长停滞和增强分化的抵抗力,但对HL60 WT细胞。规避对PMA的耐药性与ERK的持续活化有关。这些数据表明,HL60细胞长期暴露于TLK199会改变PMA对细胞ERK的激活,这可能有助于WT和耐药细胞对PMA的差异反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号